Quantcast

Latest Pneumococcal vaccine Stories

2009-09-30 14:23:27

Many people who have died of H1N1 influenza in the United States had other bacterial infections that likely contributed to their deaths, health officials say. A report published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report says those who died of H1N1 influenza had co-infections with a common bacteria such as Streptococcus pneumoniae or pneumococcus. The CDC report included an analysis of specimens taken from 77 fatal cases of H1N1. Bacterial...

2009-09-25 10:08:00

COLLEGEVILLE, Pa., Sept. 25 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the company's pneumococcal conjugate vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent Adsorbed]). The CHMP recommends approval of Prevenar 13 for active immunization of children aged 6 weeks to 5 years for...

2009-09-22 10:33:00

NEW YORK, Sept. 22 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry http://www.reportlinker.com/p0120962/Vaccines-2009-World-Market-Analysis-Key-Players-and-Critical-Trends-in-a-Fast-Changing-Industry.html The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the...

2009-09-11 14:03:42

Prevention and treatment of pneumonia are critical to reducing child mortality, reaching Millennium Development Goal 4 New World Health Organization data to be published in this week's edition of the Lancet will shed new light on two leading causes of pneumonia, the world's leading killer of children under age 5, both globally and within specific countries. The results, which are the first ever available at the country level, are expected to serve as a clarion call to developing country...

2009-09-08 07:35:21

A new vaccine against pneumonia may offer better protection from chronic obstructive pulmonary disease (COPD) patients than the currently accepted vaccine, according to recent research that will be published in the September 15 issue of the American Journal of Respiratory and Critical Care Medicine, a publication of the American Thoracic Society. Because pneumonia disproportionately affects patients with COPD and frequently causes exacerbations, the Centers for Disease Control currently...

2009-07-22 09:20:00

WASHINGTON, July 22 /PRNewswire/ -- Young adults may have grown up in an era of information overload, but they have alarmingly little awareness of the risks of vaccine-preventable diseases and the need to keep up with vaccinations into adulthood, new data show. For example, 84 percent of Americans over the age of 50 know that tetanus causes lockjaw and that they need to get a tetanus shot every 10 years. By contrast, just 49 percent of young adults aged 18 to 26 are aware of that...

2009-07-14 07:00:00

COLLEGEVILLE, Pa., July 14 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the Chilean Ministry of Health, MINSAL (Ministerio de Salud), has become the first government agency to approve Prevenar 13* Valent, (Pneumococcal Conjugate Vaccine 13 Valent (Diphtheria CRM(197) Protein)) for infants and young children. Prevenar 13 Valent is approved for active immunization of children aged 6 weeks through 5 years for the prevention of invasive...

2009-07-08 07:37:21

Infants who received two or three primary doses of the 7-valent pneumococcal conjugate vaccine (PCV-7) both had a decreased rate of carrying pneumococcal microorganisms that can cause pneumonia and other infections, compared to infants who were not vaccinated, according to a study in the July 8 issue of JAMA.Crowded infant vaccine schedules and less favorable cost-effectiveness calculations have prompted exploration of reduced-dose vaccine schedules other than the currently recommended...

5cb8c8d217db08f3a07e4f9a0cc14d461
2009-06-13 06:50:00

The Bill & Melinda Gates Foundation and the governments of Britain, Italy, Canada, Russia and Norway announced a $1.5 billion initiative on Friday to provide poor nations better access to vaccines against pneumococcal disease such as meningitis and pneumonia. The Advance Market Commitment program creates financial incentive with a guaranteed price to entice companies to make the substantial investments required to develop new vaccines. The Geneva-based GAVI Alliance, the Gates-funded...

2009-06-12 11:33:22

A $1.5 billion plan to save the world's poorest children from pneumococcal diseases was activated Friday in Lecce, Italy, international aid groups said. Representatives of five countries and four international aid groups officially made good on commitments promised in 2007 to speed delivery of pneumococcal vaccines that kill 1.6 million people year, including an estimated 1 million children under age 5. Italy donated $635 million, Britain $485 million, Canada $200 million, Russia $80 million,...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related